These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26819214)

  • 1. [Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].
    Feichtinger M; Stopp T; Göbl C
    Wien Med Wochenschr; 2016 Mar; 166(3-4):139-42. PubMed ID: 26819214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic Ovary Syndrome, Obesity, and Pregnancy.
    Joham AE; Palomba S; Hart R
    Semin Reprod Med; 2016 Mar; 34(2):93-101. PubMed ID: 26854709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
    Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ; Pasquali R; Teede HJ; Hoeger KM; Norman RJ
    Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do women with PCOS have a unique predisposition to obesity?
    Hoeger KM; Oberfield SE
    Fertil Steril; 2012 Jan; 97(1):13-7. PubMed ID: 22192136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G; Davidson CR; Billings DL
    Hum Fertil (Camb); 2015 Mar; 18(1):16-21. PubMed ID: 24921163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.
    Caserta D; Adducchio G; Picchia S; Ralli E; Matteucci E; Moscarini M
    Gynecol Endocrinol; 2014 Jun; 30(6):397-402. PubMed ID: 24552422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome and weight management.
    Moran LJ; Lombard CB; Lim S; Noakes M; Teede HJ
    Womens Health (Lond); 2010 Mar; 6(2):271-83. PubMed ID: 20187731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome.
    Aubuchon M; Laughbaum N; Poetker A; Williams D; Thomas M
    Fertil Steril; 2009 Apr; 91(4 Suppl):1336-8. PubMed ID: 18555225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
    PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.
    Panidis D; Tziomalos K; Papadakis E; Vosnakis C; Chatzis P; Katsikis I
    Endocrine; 2013 Dec; 44(3):583-90. PubMed ID: 23625194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
    Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
    Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies for infertile women with polycystic ovary syndrome.
    Vitek W; Hoeger K; Legro RS
    Minerva Ginecol; 2016 Aug; 68(4):450-7. PubMed ID: 26765152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction: Determinants of polycystic ovary syndrome.
    Azziz R
    Fertil Steril; 2016 Jul; 106(1):4-5. PubMed ID: 27238627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and polycystic ovary syndrome.
    Naderpoor N; Shorakae S; Joham A; Boyle J; De Courten B; Teede HJ
    Minerva Endocrinol; 2015 Mar; 40(1):37-51. PubMed ID: 25411807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy complications in women with polycystic ovary syndrome.
    Boomsma CM; Fauser BC; Macklon NS
    Semin Reprod Med; 2008 Jan; 26(1):72-84. PubMed ID: 18181085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
    Thomson RL; Buckley JD; Brinkworth GD
    Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.